Open access · US-GOV via ClinicalTrials.gov Clinical trial

Multicentric Randomized Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer in Elderly Unfit Patients According to Geriatric Evaluation

Authors not listed

Gustave Roussy, Cancer Campus, Grand Paris · 2013

Dysbiosis Human Randomized controlled trial

Abstract

To test whether cetuximab improves efficacy/tolerance as compared to methotrexate in first line treatment of unfit patients ³ 70 years old with recurrent and /or metastatic HNSCC. Efficacy assessed by failure free survival

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-25 MST

Cite this

APA

Anonymous. (2013). Multicentric Randomized Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer in Elderly Unfit Patients According to Geriatric Evaluation. <em>Gustave Roussy, Cancer Campus, Grand Paris</em>. https://clinicaltrials.gov/study/NCT01884623

Vancouver

Anonymous. Multicentric Randomized Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer in Elderly Unfit Patients According to Geriatric Evaluation. Gustave Roussy, Cancer Campus, Grand Paris. 2013.

BibTeX

@misc{anon2013Multic, title = {Multicentric Randomized Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer in Elderly Unfit Patients According to Geriatric Evaluation}, author = {Anonymous}, journal = {Gustave Roussy, Cancer Campus, Grand Paris}, year = {2013}, }